Skip to content

CeriBell, Inc. CBLL Free cash flow

Free cash flow at other companies

IAR
Integra LifeSciencesIART
-$5.05M+87.4%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.61M-35.5%
iRadimed logo
iRadimedIRMD
$7.89M+1,226%
Teladoc Health logo
Teladoc HealthTDOC
$7.86M-40.5%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-$28.16M-27.7%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
-$33.08M-91.1%

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s free cash flow?
CeriBell, Inc. (CBLL) reported free cash flow of -$19.42M in Q1 2026.
How has CeriBell, Inc.'s free cash flow changed year-over-year?
CeriBell, Inc.'s free cash flow decreased by 68.1% year-over-year, from -$11.55M to -$19.42M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.